Back
Newmont Corp. 10K Form
Buy
61
NEM
Newmont Corp.
Last Price:
$90.74
Seasonality Move:
5.89%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-04-29 | 10Q | NEM/Newmont Corp. Quarterly |
| 2024-02-29 | 10K | NEM/Newmont Corp. Annual |
| 2023-10-26 | 10Q | NEM/Newmont Corp. Quarterly |
| 2023-07-20 | 10Q | NEM/Newmont Corp. Quarterly |
| 2023-04-27 | 10Q | NEM/Newmont Corp. Quarterly |
| 2023-02-23 | 10K | NEM/Newmont Corp. Annual |
Receive NEM News And Ratings
See the #1 stock for the next 7 days that we like better than NEM
NEM Financial Statistics
Sales & Book Value
| Annual Sales: | $18.6B |
|---|---|
| Cash Flow: | $1.6B |
| Price / Cash Flow: | 16.38 |
| Annual Sales: | $30.21 |
| Price / Book: | 2.94 |
Profitability
| EPS (TTM): | 6.43280 |
|---|---|
| Net Income (TTM): | $7.2B |
| Gross Margin: | $6.4B |
| Return on Equity: | 23.04% |
| Return on Assets: | 13.03% |
Newmont Corp. Earnings Forecast
Key Newmont Corp. Financial Ratios
-
The Gross Profit Margin over the past 45 years for NEM is 34.62%.
-
The Selling, General & Administrative Expenses for NEM have been equal to 2.38% of Gross Profit Margin.
-
The Research & Development expenses have been 1.06% of Revenue.
-
The Interest Expense is 11.62% of Operating Income.
-
The Net Earning history of NEM is 17.85% of Total Revenues.
-
Per Share Earnings over the last 45 years have been positive in 16 years.
Newmont Corp. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | S&P500 |
|---|---|
| Industry: | Metals & Mining |
| Sector: | Materials |
| Current Symbol: | NEM |
| CUSIP: | 651639 |
| Website: | newmont.com |
Debt
| Debt-to-Equity Ratio: | 0.17 |
|---|---|
| Current Ratio: | 2.04 |
| Quick Ratio: | 1.38 |
Price-to-Earnings
| Trailing P/E Ratio: | 31.38 |
|---|---|
| Forward P/E Ratio: | 12.11 |
NEM Technical Analysis vs Fundamental Analysis
Buy
61
Newmont Corp. (NEM)
is a Buy
Is Newmont Corp. a Buy or a Sell?
-
Newmont Corp. stock is rated a BuyThe current Newmont Corp. [NEM] share price is $89.65. The Score for NEM is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.